2Seventy Stock Based Compensation from 2010 to 2024
| TSVT Stock | USD 3.99 0.03 0.76% |
Stock Based Compensation | First Reported 2010-12-31 | Previous Quarter 32.2 M | Current Value 38.9 M | Quarterly Volatility 8.4 M |
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 10.8 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 0.78. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
2Seventy | Stock Based Compensation |
Latest 2Seventy Bio's Stock Based Compensation Growth Pattern
Below is the plot of the Stock Based Compensation of 2Seventy Bio over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. 2Seventy Bio's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
| Stock Based Compensation | 10 Years Trend |
|
Stock Based Compensation |
| Timeline |
2Seventy Stock Based Compensation Regression Statistics
| Arithmetic Mean | 43,798,200 | |
| Geometric Mean | 43,131,058 | |
| Coefficient Of Variation | 19.24 | |
| Mean Deviation | 6,170,720 | |
| Median | 40,801,000 | |
| Standard Deviation | 8,427,059 | |
| Sample Variance | 71T | |
| Range | 29.9M | |
| R-Value | 0.18 | |
| Mean Square Error | 74T | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | 337,007 | |
| Total Sum of Squares | 994.2T |
2Seventy Stock Based Compensation History
Other Fundumenentals of 2Seventy Bio
2Seventy Bio Stock Based Compensation component correlations
Click cells to compare fundamentals
About 2Seventy Bio Financial Statements
2Seventy Bio shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Stock Based Compensation | 32.2 M | 38.9 M | |
| Stock Based Compensation To Revenue | 0.32 | 0.30 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.